Live tape
Top 8, mentions 7d29,903NVDA14,507 mentions▲ +0.04ANT4,144 mentions▲ +0.06GOOGL2,920 mentions▲ +0.04SPY2,244 mentions▲ +0.05QQQ1,800 mentions▲ +0.03SPCX1,744 mentions▲ +0.08AMD1,363 mentions▲ +0.06AAPL1,181 mentions▲ +0.04

Equity · Healthcare

RXRX

NASDAQ

Recursion Pharmaceuticals (RXRX)

2.52 USD −5.26% vs prior close Nov 20, 2026
Recursion Pharmaceuticals, Inc. price graph
64 sessions
5 2 24 Aug 20 Nov

The line runs 3.26 USD on 24 August through 2.52 USD on 20 November, on a scale from 2 to 5. Days the market did not trade hold the previous close, flat.

Market cap
1.6B USD
Revenue, year to Dec 2025
74.7M USD
EPS, diluted, year to Dec 2025
−1.44 USD
52-week range
2.52 USD – 5 USD
Avg volume
1.6M
Mentions, 30 days
7
Net sentiment
+0.06

as of Nov 20, 2026

Have Recursion Pharmaceuticals (RXRX) insiders bought or sold shares recently?

In the 90 days to 22 Nov 2026, Recursion Pharmaceuticals insiders reported 5 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 23 Oct 2025, show no open-market purchase.

Form 4, 90 days to 22 Nov 2026, newest reported trade 3 Nov 2026

0buys
5sells
$701Knet sold
8other filings
Have Recursion Pharmaceuticals (RXRX) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
03 Nov 2026Borgeson BlakeDirectorSell40,000155K USD
06 Oct 2026Borgeson BlakeDirectorSell50,000242K USD
06 Oct 2026HERSHBERG ROBERTDirectorSell25,000125K USD
08 Sep 2026Khan NajatCEO and PresidentSell22,40879K USD
01 Sep 2026Borgeson BlakeDirectorSell30,000100K USD
Sold5 open-market sales167,408$701K
8 other filings in the window: grants, exercises, tax withholding and transfers, not trades
Have Recursion Pharmaceuticals (RXRX) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
16 Nov 2026Hallett DavidChief Scientific OfficerTax withheld26,65785K USD
16 Nov 2026Khan NajatCEO and PresidentTax withheld85,815273K USD
16 Nov 2026Taylor Ben RChief Financial OfficerTax withheld25,01880K USD
02 Nov 2026Hassan FredDirectorAward156,658
06 Oct 2026HERSHBERG ROBERTDirectorOption exercise25,00056K USD
01 Oct 2026Dar ZavainDirectorAward4,607
01 Oct 2026Li Dean YDirectorAward3,378
15 Sep 2026Taylor Ben RChief Financial OfficerTax withheld5,39618K USD

Which funds hold Recursion Pharmaceuticals (RXRX)?

11 of the 45 institutional funds we track reported a Recursion Pharmaceuticals position for the quarter ended 30 Sep 2026 — a combined 262.3M USD; the latest of those filings landed 16 Nov 2026.

Form 13F

Which funds hold Recursion Pharmaceuticals (RXRX)?
FundPositionSharesValueShares q/q
ARK Investment ManagementHeld (±25%)44,745,025184.8M USD+8.2%
Two Sigma InvestmentsAdded7,951,07732.8M USD+137.1%
Millennium ManagementAdded4,044,85016.7M USD+120.5%
Citadel AdvisorsAdded2,962,09712.2M USD+2,205.5%
Marshall WaceTrimmed2,070,6938.6M USD−56.1%
Man GroupHeld (±25%)650,2102.7M USD−15.1%
Balyasny Asset ManagementAdded541,5492.2M USD+53.1%
Point72 Asset ManagementNew position238,435985K USD
AQR Capital ManagementTrimmed199,562824K USD−52.7%
Bridgewater AssociatesAdded96,596399K USD+156.4%

Showing the 10 largest of 11 reported positions. The figures above count all of them.

What has been filed or recorded for Recursion Pharmaceuticals (RXRX)?

The filings we hold for Recursion Pharmaceuticals, newest first: 6 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 30 Oct 2026. No next earnings date is announced in SEC filings yet.

What has been filed or recorded for Recursion Pharmaceuticals (RXRX)?
And
30 Oct 2026Fails to deliverShares failed to deliver36 shares153 USD notional · <0.001% of shares out
21 Oct 2026Fails to deliverShares failed to deliver94,866 shares347K USD notional · 0.015% of shares out
20 Oct 2026Fails to deliverShares failed to deliver108,434 shares391K USD notional · 0.017% of shares out
14 Oct 2026Fails to deliverShares failed to deliver717,024 shares2.8M USD notional · 0.115% of shares out
13 Oct 2026Fails to deliverShares failed to deliver623,513 shares2.5M USD notional · 0.100% of shares out
09 Oct 2026Fails to deliverShares failed to deliver15,914 shares63K USD notional · 0.003% of shares out
30 Sep 2026Quarterly earningsQ3 2026 reportedEPS −0.22 USDRevenue $19M
30 Sep 2026FinancialsTotal assets1.2B USDat period end
30 Sep 2026FinancialsTotal equity905.8M USDat period end
30 Jun 2026Quarterly earningsQ2 2026 reportedEPS −0.25 USDRevenue $8M
31 Mar 2026Quarterly earningsQ1 2026 reportedEPS −0.22 USDRevenue $6M
31 Dec 2025Annual reportFY 2025 reportedEPS −1.44 USDRevenue $75M
31 Dec 2025FinancialsRevenue74.7M USDfiscal year
31 Dec 2025FinancialsNet income−644.8M USDfiscal year
31 Dec 2025FinancialsDiluted EPS−1.44 USDfiscal year
30 Sep 2025Quarterly earningsQ3 2025 reportedEPS −0.36 USDRevenue $5M
30 Jun 2025Quarterly earningsQ2 2025 reportedEPS −0.41 USDRevenue $19M
31 Mar 2025Quarterly earningsQ1 2025 reportedEPS −0.50 USDRevenue $15M
31 Dec 2024Annual reportFY 2024 reportedEPS −1.69 USDRevenue $59M

What is Reddit saying about Recursion Pharmaceuticals (RXRX)?

Reddit mentioned RXRX 7 times in the 30 days to 21 November 2026, across 2 of the communities we track. All of them were scored for sentiment: 43% read bullish, 0% bearish and 57% neither. Reddit data updated 21 November 2026.

30-day window, Method

7mentions, 30 days
43%bullish
0%bearish
2communities
−9pointsagainst the market

How do Reddit mentions of Recursion Pharmaceuticals (RXRX) compare with its price?

Share ↗
7 mentions

Is the Reddit crowd more bullish on Recursion Pharmaceuticals than on the market?

RXRX reads 40% bullish, 12 points below the market (52%). Over 90 days the gap has run from -12 to +35 points.

RXRX
40%
bullish, 21 Nov
Market
52%
bullish, all Reddit, 21 Nov
Gap
−12 pts
RXRX against market
30%50%70%90%NovOctSep
30%50%70%90%NovOctSep

Which subreddits are talking about Recursion Pharmaceuticals (RXRX)?

30 days

Which subreddits are talking about Recursion Pharmaceuticals (RXRX)?
CommunityShareMentionsNet sentiment
r/wallstreetbets86%6+0.05
r/investing14%1+0.10

What do people ask about Recursion Pharmaceuticals (RXRX)?

From live data
What did Recursion Pharmaceuticals shares close at?2.52

Recursion Pharmaceuticals closed at 2.52 USD on 20 Nov 2026, down 5.26% on the close before. That is the end-of-day price from Finazon, not a live quote.

What is Recursion Pharmaceuticals’ market cap?1.6B

Recursion Pharmaceuticals is worth 1.6B USD by market value as of 20 Nov 2026, which is the share price times the shares on issue from its SEC filings.

What is Recursion Pharmaceuticals’ revenue?74.7M

Recursion Pharmaceuticals reported revenue of 74.7M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings

Have Recursion Pharmaceuticals insiders bought or sold shares recently?5 sales

In the 90 days to 22 Nov 2026, Recursion Pharmaceuticals insiders reported 5 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 23 Oct 2025, show no open-market purchase. A further 8 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders

Which funds own Recursion Pharmaceuticals?11 of 45

11 of the 45 funds we track reported a Recursion Pharmaceuticals position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported positions were ARK Investment Management, Two Sigma Investments and Millennium Management. See Funds

When did Recursion Pharmaceuticals last report earnings?−0.22

Recursion Pharmaceuticals last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of −0.22 USD; no next date is announced in SEC filings yet. See Filings

What is Reddit saying about Recursion Pharmaceuticals?5 mentions

Recursion Pharmaceuticals was mentioned 5 times in the last 7 days across the finance subreddits we track, and 7 times over the trailing 30 days. Of the 7 mentions scored for sentiment, 43% read bullish and 0% bearish. That is a social signal, not investment advice. See Reddit

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. RedditReddit ingest across the tracked finance subreddits
  4. SEC EDGARForm 4 filings (insider transactions)
  5. SEC EDGAR13F filings
  6. SECSEC fails-to-deliver (CNS) data
  7. SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
  8. SEC EDGARreported earnings figures and scheduled report dates
  9. SEC EDGARValuation computed from SEC EDGAR filings
  10. SEC filingAbout text: the company's latest annual report filed with the SEC (Business section), summarised in our own words